Search for: "Janssen Research "
Results 181 - 200
of 200
Sort by Relevance
|
Sort by Date
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
10 Aug 2009, 10:06 pm
Plaintiffs for Levaquin lawsuits claim the manufacturer, Ortho-McNeil-Janssen Pharmaceuticals, failed to research its product adequately prior to bringing Levaquin to market in 1996 and failed to warn about adverse effects to the tendon. [read post]
6 Aug 2009, 6:50 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
23 Jun 2009, 5:47 am
Erick Janssen and Stephanie Sanders, both of the Kinsey Institute. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
5 Sep 2008, 11:01 pm
(IPRoo), (Australian Patent Law), (Managing Intellectual Property), Global Global - General Intellectual property business models: (IP Thinktank), Kicking own goal by attempting to restrain (internet) publication: (IP Thinktank), New Geneva think tank IQsensato features developing nation research on IP: (Intellectual Property Watch), WIPO releases 2008 World Intellectual Property Report: (IP Menu News), Bringing the developed world to heel through the use of IP… [read post]
5 Sep 2008, 8:28 am
Prosthetics Research Assocs., Inc. v. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
1 Aug 2008, 12:33 pm
§ 1407 and Transfers Actions to District of Minnesota Fifteen (15) individual and class action lawsuits were filed in seven (7) different federal district courts against Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Johnson & Johnson Pharmaceutical Research & Development, among others, alleging “that the antibiotic Levaquin causes tendon rupture, and the warnings provided by defendants informing Levaquin users of… [read post]
11 Jul 2008, 4:30 am
: (IP Business Strategy Blog) Global - Copyright LegalTorrents – ‘online community created to discover and distribute CC licensed digital media’: (creativecommons.org), WIPO workshop to probe copyright issues arising from the preservation of digital content: (WIPO), Jeff Roberts on avatar rights: (IPKat) Events 16 July: US LSI ‘Patent claim construction workshop’ – Seattle: (Patent Docs), 16-17 July: EPO seminar on… [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical Boards of Appeal… [read post]
25 Jun 2008, 6:34 pm
Researchers estimate that about a third of all nursing home patients have been given antipsychotic drugs. [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
7 Mar 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO upholds one of Wisconsin Alumni Research Foundation (WARF’s) human stem cell patents (decisions are pending on two other patents): (IPKat), (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (Patent Baristas), (IPBiz), English High Court rules Qualcomm’s patents invalid in battle against Nokia: (Philip Brooks),… [read post]
4 Mar 2008, 1:49 am
Janssen, discussing the new Federal Rules of Civil Procedure and their impact on litigators can be downloaded at [feeds.feedburner]. com/Westcast. [read post]
29 Feb 2008, 8:00 am
., claiming infringement of three patents covering its enlarged-prostate treatment, Avodart; Barr challenges GSK’s Avodart patent: (IP Law360), (GenericsWeb),Fosamax (Alendronate) – Courts in Netherlands and France both invalidate Merck Sharp & Dohme’s European patents for Alendronate: (IP Law360), (The IP Factor), (Generic Pharmaceuticals & IP), Hectorol – Genzyme Corp launches US patent suit against Pentech Pharmaceuticals to prevent it from… [read post]
6 Jul 2007, 4:29 am
We've already deplored the recent decision of the West Virginia Supreme Court rejecting the learned intermediary rule outright, State ex rel. [read post]
12 Apr 2007, 1:33 am
"More likely than not" seems to us to be farther away from the actual comfort level that professionals need before making a decision than the existing "reasonable professional certainty" standard.According to the Reporter's Notes (pp. 135-36), somebody did some ad hoc research among some doctors and scientists attending a recent medico-legal conference (not necessarily a representative sampling, we suspect, given the setting) by eliciting criticism of the… [read post]
